Protective effects of fatty acid amide hydrolase inhibition in UVB-activated microglia.

Endocannabinoid system FAAH inhibition Microglia Neuroinflammation UVB

Journal

Biochimica et biophysica acta. Molecular and cell biology of lipids
ISSN: 1879-2618
Titre abrégé: Biochim Biophys Acta Mol Cell Biol Lipids
Pays: Netherlands
ID NLM: 101731727

Informations de publication

Date de publication:
08 Jun 2024
Historique:
received: 08 02 2024
revised: 30 05 2024
accepted: 07 06 2024
medline: 11 6 2024
pubmed: 11 6 2024
entrez: 10 6 2024
Statut: aheadofprint

Résumé

Neuroinflammation is a hallmark of several neurodegenerative disorders that has been extensively studied in recent years. Microglia, the primary immune cells of the central nervous system (CNS), are key players in this physiological process, demonstrating a remarkable adaptability in responding to various stimuli in the eye and the brain. Within the complex network of neuroinflammatory signals, the fatty acid N-ethanolamines, in particular N-arachidonylethanolamine (anandamide, AEA), emerged as crucial regulators of microglial activity under both physiological and pathological states. In this study, we interrogated for the first time the impact of the signaling of these bioactive lipids on microglial cell responses to a sub-lethal acute UVB radiation, a physical stressor responsible of microglia reactivity in either the retina or the brain. To this end, we developed an in vitro model using mouse microglial BV-2 cells. Upon 24 h of UVB exposure, BV-2 cells showed elevated oxidative stress markers and, cyclooxygenase (COX-2) expression, enhanced phagocytic and chemotactic activities, along with an altered immune profiling. Notably, UVB exposure led to a selective increase in expression and activity of fatty acid amide hydrolase (FAAH), the main enzyme responsible for degradation of fatty acid ethanolamides. Pharmacological FAAH inhibition via URB597 counteracted the effects of UVB exposure, decreasing tumor necrosis factor α (TNF-α) and nitric oxide (NO) release and reverting reactive oxidative species (ROS), interleukin-1β (IL-1β), and interleukin-10 (IL-10) levels to the control levels. Our findings support the potential of enhanced fatty acid amide signaling in mitigating UVB-induced cellular damage, paving the way to further exploration of these lipids in light-induced immune responses.

Identifiants

pubmed: 38857757
pii: S1388-1981(24)00074-X
doi: 10.1016/j.bbalip.2024.159524
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

159524

Informations de copyright

Copyright © 2024. Published by Elsevier B.V.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Veronica Carnicelli (V)

Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, 67100 L'Aquila, Italy.

Noemi De Dominicis (N)

Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, 67100 L'Aquila, Italy; Department of Physics, University of Trento, 38123 Trento, Italy.

Lucia Scipioni (L)

Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, 67100 L'Aquila, Italy; European Center for Brain Research/IRCCS Santa Lucia Foundation, 00143 Rome, Italy.

Marina Fava (M)

Department of Medicine, Campus Bio-Medico University of Rome, 00128 Rome, Italy.

Federico Fanti (F)

Department of Bioscience and Technology for Agriculture, Food and Environment, Campus Universitario di Coste Sant'Agostino, University of Teramo, Italy.

Benedetta Cinque (B)

Department of Life, Health & Environmental Sciences, University of L'Aquila, 67100 L'Aquila, Italy.

Alessandro Leuti (A)

European Center for Brain Research/IRCCS Santa Lucia Foundation, 00143 Rome, Italy; Department of Medicine, Campus Bio-Medico University of Rome, 00128 Rome, Italy.

Clotilde Beatrice Angelucci (CB)

Department of Veterinary Medicine, University of Teramo, 64100 Teramo, Italy.

Anna Rita Lizzi (AR)

Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, 67100 L'Aquila, Italy.

Roberto Giacominelli-Stuffler (R)

Department of Veterinary Medicine, University of Teramo, 64100 Teramo, Italy.

Vincenzo Flati (V)

Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, 67100 L'Aquila, Italy.

Manuel Sergi (M)

Department of Chemistry, Sapienza University of Rome, Rome, Italy.

Dario Compagnone (D)

Department of Bioscience and Technology for Agriculture, Food and Environment, Campus Universitario di Coste Sant'Agostino, University of Teramo, Italy.

Anna Maria Sardanelli (AM)

Department of Translational Biomedicine and Neuroscience 'DiBraiN', University of Bari "Aldo Moro", 70121 Bari, Italy.

Annamaria Tisi (A)

Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, 67100 L'Aquila, Italy.

Sergio Oddi (S)

European Center for Brain Research/IRCCS Santa Lucia Foundation, 00143 Rome, Italy; Department of Veterinary Medicine, University of Teramo, 64100 Teramo, Italy. Electronic address: soddi@unite.it.

Mauro Maccarrone (M)

Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, 67100 L'Aquila, Italy; European Center for Brain Research/IRCCS Santa Lucia Foundation, 00143 Rome, Italy. Electronic address: mauro.maccarrone@univaq.it.

Classifications MeSH